Journal
Journal of Clinical Investigation
Publication Date
5-3-2024
Volume
134
Issue
11
First Page
e177427
Document Type
Open Access Publication
DOI
10.1172/JCI177427
Rights and Permissions
Prabakaran AD, McFarland K, Miz K, Durumutla HB, Piczer K, El Abdellaoui Soussi F, Latimer H, Werbrich C, Chung HJ, Blair NS, Millay DP, Morris AJ, Prideaux B, Finck BN, Quattrocelli M. Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1α/Lipin1 axis in an aging-related sarcopenia model. J Clin Invest. 2024 May 3;134(11):e177427. doi: 10.1172/JCI177427. © 2024, Prabakaran et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.
Recommended Citation
Prabakaran, Ashok D.; McFarland, Kevin; Miz, Karen; Durumutla, Hima Bindu; Piczer, Kevin; El Abdellaoui Soussi, Fadoua; Latimer, Hannah; Werbrich, Cole; Chung, Hyun-Jy; Blair, N. Scott; Millay, Douglas P.; Morris, Andrew J.; Prideaux, Brendan; Finck, Brian N.; and Quattrocelli, Mattia, "Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1α/Lipin1 axis in an aging-related sarcopenia model." Journal of Clinical Investigation. 134, 11. e177427 (2024).
https://digitalcommons.wustl.edu/oa_4/3909
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
